Intel’s stock recovery has encountered an unexpected obstacle during the holiday period. Reports that its crucial partner, Nvidia, has halted testing of a key manufacturing process have cast doubt on the chipmaker’s ambitious “foundry-first” strategy. Investors are now left to assess whether the issues with the pivotal 18A production node represent a temporary setback or a more fundamental challenge to the company’s turnaround plans.
A Contradiction in Market Sentiment
This development presents a stark contrast to recent analyst optimism. On December 16, Bank of America (BofA) raised its price target for Intel from $34 to $40. While the bank maintained its “underperform” rating, it pointed to growing opportunities in the “Advanced Packaging” segment. The discrepancy between this positive outlook on packaging technology and the reported manufacturing difficulties underscores the volatile proving phase the corporation is currently navigating.
The trigger for the pre-market pressure and a 2.1% share price decline to $35.59 was a Reuters report published late Wednesday. According to the report, AI giant Nvidia has paused its evaluation of Intel’s new 18A fabrication process. The reason cited was that the production yield failed to meet required benchmarks. This move carries significant weight, as the 18A node is considered the technological cornerstone of Intel’s strategy to regain production parity with industry leader TSMC by 2026.
Operational Progress Amid Strategic Concerns
Operationally, Intel’s results are mixed. Its Fab 52 facility in Arizona is now reportedly producing approximately 40,000 wafers per month, though primarily for its own “Panther Lake” processors. While volume is increasing, the absence of a major external flagship customer for the 18A technology remains a persistent concern for the investment community.
Should investors sell immediately? Or is it worth buying Intel?
This setback arrives during a year of profound structural change for Intel. Under new CEO Lip-Bu Tan, the foundry business has been spun off into a separate subsidiary, a move designed to reduce barriers for external clients.
A Stronger Financial Foundation
Unlike the situation in 2024, the company now operates with a substantially more stable financial safety net. Thanks to finalized CHIPS Act funding totaling $7.86 billion, the risk of insolvency has been effectively eliminated. The stock has recovered nearly 80% from its annual lows and is trading in the $35 to $37 range, suggesting the market has already priced in certain manufacturing execution risks.
As trading resumes on Friday, December 26, market focus will likely shift to any potential management commentary on the situation. The next critical catalyst will come in late January 2026 with the quarterly earnings report, where Intel must provide concrete updates on its order pipeline. From a technical analysis perspective, bulls will need to defend the support level at $35 to keep the medium-term upward scenario intact.
Ad
Intel Stock: Buy or Sell?! New Intel Analysis from December 25 delivers the answer:
The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 25.
Intel: Buy or sell? Read more here...








